IVBT Stock Chart & Stats
$0.02
$0.00(0.00%)
At close: 4:00 PM EDT
$0.02
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.02 - $0.02
Previous CloseN/A
Volume1.00
Average Volume (3M)N/A
Market Cap
$4.49K
Enterprise Value$183.64K
Total Cash (Recent Filing)$107.53K
Total Debt (Recent Filing)$605.06K
Price to Earnings (P/E)―
Beta-4.61
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.30
Shares Outstanding22,470,240
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)-5.00
Price to Sales (P/S)0.00
P/FCF Ratio-27.66
Enterprise Value/Market Cap40.86
Enterprise Value/Revenue1.75
Enterprise Value/Gross Profit3.56
Enterprise Value/Ebitda-0.04
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Innovation1 Biotech News
IVBT FAQ
What was Innovation1 Biotech’s price range in the past 12 months?
Innovation1 Biotech lowest stock price was $0.02 and its highest was $0.02 in the past 12 months.
What is Innovation1 Biotech’s market cap?
Innovation1 Biotech’s market cap is $4.49K.
When is Innovation1 Biotech’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Innovation1 Biotech’s earnings last quarter?
Currently, no data Available
Is Innovation1 Biotech overvalued?
According to Wall Street analysts Innovation1 Biotech’s price is currently Overvalued.
Does Innovation1 Biotech pay dividends?
Innovation1 Biotech does not currently pay dividends.
What is Innovation1 Biotech’s EPS estimate?
Innovation1 Biotech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Innovation1 Biotech have?
Innovation1 Biotech has 22,470,240 shares outstanding.
What happened to Innovation1 Biotech’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Innovation1 Biotech?
Currently, no hedge funds are holding shares in IVBT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Innovation1 Biotech
Innovation1 Biotech Inc. functions as a drug discovery enterprise, primarily engaged in creating modified botanical Schedule 1 molecules for use within the United States. The firm's pipeline encompasses five entirely synthetic, proprietary prodrugs that are currently in preclinical development, each designed to tackle a unique set of medical conditions. Specifically, these include a psychedelic compound derived from mushrooms, aimed at treating post-traumatic stress disorder and depression; an innovative cannabinoid and tree bark-sourced psychedelic intended to combat addiction; and three additional cannabinoid prodrugs targeting refractory pediatric epilepsy, hypertrophic scarring, and inflammation of the eye. Established in 2014 and headquartered in New York, New York, the company was previously named Gridiron BioNutrients, Inc. before adopting its current moniker, Innovation1 Biotech Inc., in March 2022.